Given the high specificity and selectivity of MUC16 and MSLN as diagnostic markers, they have very high potential as theranostic targets to diagnose, treat, and monitor ovarian cancers (Zhao et al., 2023). The gene discussed is MUC16; the disease is ovarian cancer.